Nav: Home

Cancer-causing parasite may accelerate wound healing

October 20, 2015

It's short, ugly and deadly. But James Cook University scientists have found a cancer-causing, parasitic worm could help patients recover from their wounds.

JCU scientists at the Australian Institute of Tropical Health and Medicine (AITHM) have discovered that the parasitic worm that kills tens of thousands of people every year may also supercharge recovery from wounds.

The oriental liver fluke, Opisthorchis viverrini is caught by eating raw fish. It infects millions of people in south-east Asia and kills 26,000 people each year due to a parasite-induced bile duct cancer it causes, known as cholangiocarcinoma (CCA).

JCU scientists, Dr Michael Smout and Professor Alex Loukas found that a growth factor secreted by the one centimetre-long worm drives wound healing and blood vessel growth. However an unfortunate consequence of this accelerated wound repair over many years is an increased risk of developing liver cancer.

Dr Smout said the discovery means it's possible the growth factor could be used to accelerate the healing of chronic wounds such as diabetic ulcers and to develop a vaccine against the worm-induced cancer.

He said the vaccine would obviously benefit the people directly at risk of cancer, but the growth factor would also benefit the developed world as a possible wound healing agent.

"Diabetes is a big problem as we live longer and get heavier," he said. "There are increasing numbers of inflammatory diseases such as diabetes and associated non-healing wounds. A powerful wound healing agent designed by millennia of host-parasite co-evolution may accelerate the impaired healing processes that plague diabetic and elderly patients"

Dr Smout said the parasite could live for decades in the human body before CCA developed and it had an incentive to keep its host healthy while chewing away at its cells.

He said scientists are still learning how this growth factor controls healing, and ultimate development of the discovery as a healing agent or vaccine was still a number of years away.
-end-


James Cook University

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...